Hemo Bioengineering Ltd

Looking for potential distributors and partners for our medical device products in different markets! Interested parties, pls email enquire@hemocorp.com to let us meet you. Headquartered in Singapore, the HEMO Group is a fast-growing platform company that offers innovative neuro- and peripheral interventional medical devices to improve the health and quality of life of patients. Our portfolio of neuro-interventional products covers ischemic stroke, hemorrhagic stroke and neuro access. We pioneered Afentta® – the first domestic aspiration catheter to be approved by China’s NMPA and commercialized. Our global R&D resources also include R&D centres in Singapore, China and the U.S. as well as a network of key opinion leaders and industry experts. Our core leadership team comprises a seasoned team of industry veterans who hail from established MNCs and Fortune 500 companies in the medtech/medical device space.